利润表(京新药业)
上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
一、营业总收入(元) | 3,208,743,897.71 | 2,149,921,275.37 | 1,060,660,180.25 | 3,998,835,219.87 | 2,925,537,429.00 | 1,936,552,392.84 | 960,425,636.79 |
营业收入(元) | 3,208,743,897.71 | 2,149,921,275.37 | 1,060,660,180.25 | 3,998,835,219.87 | 2,925,537,429.00 | 1,936,552,392.84 | 960,425,636.79 |
二、营业总成本(元) | 2,608,110,283.39 | 1,735,633,089.02 | 870,669,357.50 | 3,367,036,496.62 | 2,433,056,491.69 | 1,601,608,699.86 | 805,167,987.13 |
营业成本(元) | 1,568,830,620.06 | 1,041,122,206.89 | 510,338,395.36 | 1,976,488,431.24 | 1,433,573,708.29 | 958,381,949.85 | 480,393,479.67 |
研发费用(元) | 269,444,316.12 | 197,024,431.93 | 98,380,244.05 | 400,934,730.87 | 259,456,442.07 | 171,121,111.71 | 80,838,157.33 |
营业税金及附加(元) | 34,319,963.51 | 22,617,821.03 | 10,138,702.59 | 46,745,308.14 | 30,135,494.76 | 19,937,637.51 | 9,735,151.23 |
销售费用(元) | 587,603,792.33 | 383,812,173.66 | 207,904,913.74 | 783,527,330.14 | 605,886,403.51 | 398,280,246.70 | 200,543,328.93 |
管理费用(元) | 194,483,465.65 | 127,714,184.38 | 52,083,952.53 | 213,168,211.63 | 142,240,172.72 | 86,547,683.31 | 39,901,757.29 |
财务费用(元) | -46,571,874.28 | -36,657,728.87 | -8,176,850.77 | -53,827,515.40 | -38,235,729.66 | -32,659,929.22 | -6,243,887.32 |
其中:利息费用(元) | 7,258,253.21 | 6,094,129.70 | 3,737,540.65 | 7,314,834.56 | 6,238,304.51 | - | - |
其中:利息收入(元) | 57,501,060.04 | 41,610,562.03 | 11,743,911.24 | 60,269,451.18 | 41,938,787.01 | - | - |
三、其他经营收益 | |||||||
加:公允价值变动收益(元) | 894,143.84 | 853,424.66 | 176,705.48 | 36,770,941.18 | 1,338,184.93 | 1,002,013.70 | 596,602.74 |
加:投资收益(元) | 5,969,548.08 | -132,060.33 | 1,793,438.35 | 6,440,588.27 | 6,654,764.80 | 4,501,508.40 | 3,490,483.26 |
其中:对联营企业和合营企业的投资收益(元) | - | - | - | -6,042,420.50 | - | - | - |
资产处置收益(元) | 346,885.05 | 239,398.95 | 1,673.07 | 6,859,767.39 | 4,631,051.40 | 4,325,146.43 | -90,020.33 |
资产减值损失(元) | 101,627.74 | 1,409,155.40 | -1,934,674.71 | -21,145,432.43 | 1,480,961.20 | 3,131,992.28 | 4,525,850.69 |
信用减值损失(元) | -17,634,106.90 | -12,617,473.37 | -3,153,908.97 | -5,137,515.63 | 599,398.32 | -2,454,943.02 | -1,405,174.41 |
其他收益(元) | 81,503,553.50 | 72,130,233.36 | 15,179,922.22 | 58,471,887.63 | 28,303,902.97 | 19,169,229.71 | 12,519,639.92 |
四、营业利润(元) | 671,815,265.63 | 476,170,865.02 | 202,053,978.19 | 714,058,959.66 | 535,489,200.93 | 364,618,640.48 | 174,895,031.53 |
加:营业外收入(元) | 7,571,629.08 | 4,707,447.17 | 177,638.00 | 2,471,375.58 | 1,901,496.08 | 1,594,407.32 | 459,535.15 |
减:营业外支出(元) | 2,922,596.43 | 756,402.16 | 114,336.88 | 8,489,543.29 | 1,297,613.79 | 1,226,941.81 | 478,427.98 |
五、利润总额(元) | 676,464,298.28 | 480,121,910.03 | 202,117,279.31 | 708,040,791.95 | 536,093,083.22 | 364,986,105.99 | 174,876,138.70 |
减:所得税费用(元) | 95,904,869.65 | 74,251,591.08 | 28,905,146.70 | 84,623,219.09 | 60,140,798.91 | 46,538,933.54 | 23,127,660.79 |
六、净利润(元) | 580,559,428.63 | 405,870,318.95 | 173,212,132.61 | 623,417,572.86 | 475,952,284.31 | 318,447,172.45 | 151,748,477.91 |
(一)按经营持续性分类 | |||||||
持续经营净利润(元) | 580,559,428.63 | 405,870,318.95 | 173,212,132.61 | 623,608,462.80 | 475,952,284.31 | 318,447,172.45 | 151,748,477.91 |
终止经营净利润(元) | - | - | - | -190,889.94 | - | - | - |
(二)按所有权归属分类 | |||||||
归属于母公司股东的净利润(元) | 575,012,790.33 | 402,122,680.69 | 171,207,841.45 | 618,898,033.74 | 472,623,535.41 | 315,924,154.48 | 151,198,043.53 |
少数股东损益(元) | 5,546,638.30 | 3,747,638.26 | 2,004,291.16 | 4,519,539.12 | 3,328,748.90 | 2,523,017.97 | 550,434.38 |
扣除非经常性损益后的净利润(元) | 494,203,653.26 | 334,436,016.42 | 156,941,537.00 | 533,039,855.27 | 436,734,810.19 | 290,344,640.52 | 137,301,166.62 |
七、每股收益 | |||||||
一、基本每股收益(元) | 0.67 | 0.47 | 0.20 | 0.72 | 0.55 | 0.37 | 0.18 |
二、稀释每股收益(元) | 0.67 | 0.47 | 0.20 | 0.72 | 0.55 | 0.37 | 0.18 |
八、其他综合收益(元) | 206,930.55 | 385,583.07 | 284,399.46 | -333,762.92 | 680,903.10 | 574,986.39 | 151,432.72 |
归属于母公司股东的其他综合收益(元) | 206,537.51 | 381,592.86 | 274,282.49 | -333,902.34 | 667,605.43 | 565,024.84 | 136,141.55 |
归属于少数股东的其他综合收益(元) | 393.04 | 3,990.21 | 10,116.97 | 139.42 | 13,297.67 | 9,961.55 | 15,291.17 |
九、综合收益总额(元) | 580,766,359.18 | 406,255,902.02 | 173,496,532.07 | 623,083,809.94 | 476,633,187.41 | 319,022,158.84 | 151,899,910.63 |
归属于母公司所有者的综合收益总额(元) | 575,219,327.84 | 402,504,273.55 | 171,482,123.94 | 618,564,131.40 | 473,291,140.84 | 316,489,179.32 | 151,334,185.08 |
归属于少数股东的综合收益总额(元) | 5,547,031.34 | 3,751,628.47 | 2,014,408.13 | 4,519,678.54 | 3,342,046.57 | 2,532,979.52 | 565,725.55 |
公告日期 | 2024-10-25 | 2024-08-15 | 2024-04-24 | 2024-03-30 | 2023-10-27 | 2023-08-15 | 2023-04-26 |
审计意见(境内) | 标准无保留意见 | ||||||
原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
上市前/上市后 |
报表类型 |
一、营业总收入(元) |
营业收入(元) |
二、营业总成本(元) |
营业成本(元) |
研发费用(元) |
营业税金及附加(元) |
销售费用(元) |
管理费用(元) |
财务费用(元) |
其中:利息费用(元) |
其中:利息收入(元) |
三、其他经营收益 |
加:公允价值变动收益(元) |
加:投资收益(元) |
其中:对联营企业和合营企业的投资收益(元) |
资产处置收益(元) |
资产减值损失(元) |
信用减值损失(元) |
其他收益(元) |
四、营业利润(元) |
加:营业外收入(元) |
减:营业外支出(元) |
五、利润总额(元) |
减:所得税费用(元) |
六、净利润(元) |
(一)按经营持续性分类 |
持续经营净利润(元) |
终止经营净利润(元) |
(二)按所有权归属分类 |
归属于母公司股东的净利润(元) |
少数股东损益(元) |
扣除非经常性损益后的净利润(元) |
七、每股收益 |
一、基本每股收益(元) |
二、稀释每股收益(元) |
八、其他综合收益(元) |
归属于母公司股东的其他综合收益(元) |
归属于少数股东的其他综合收益(元) |
九、综合收益总额(元) |
归属于母公司所有者的综合收益总额(元) |
归属于少数股东的综合收益总额(元) |
公告日期 |
审计意见(境内) |
原始财报文件下载 |
Showing 1 to 46 of 46 entries